RP Healthcare Ltd 07972696 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is that of a retail pharmacy. Digita Accounts Production Advanced 6.30.9574.0 true false true 07972696 2024-04-01 2025-03-31 07972696 2025-03-31 07972696 bus:Director1 1 2025-03-31 07972696 core:AcceleratedTaxDepreciationDeferredTax 2025-03-31 07972696 core:RetainedEarningsAccumulatedLosses 2025-03-31 07972696 core:ShareCapital 2025-03-31 07972696 core:FinanceLeases core:CurrentFinancialInstruments 2025-03-31 07972696 core:CurrentFinancialInstruments 2025-03-31 07972696 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 07972696 core:Non-currentFinancialInstruments 2025-03-31 07972696 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 07972696 core:Goodwill 2025-03-31 07972696 core:MoreThanFiveYears 1 2025-03-31 07972696 core:FurnitureFittingsToolsEquipment 2025-03-31 07972696 core:LandBuildings 2025-03-31 07972696 core:MotorVehicles 2025-03-31 07972696 core:OtherProvisionsContingentLiabilities 2025-03-31 07972696 bus:SmallEntities 2024-04-01 2025-03-31 07972696 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 07972696 bus:FilletedAccounts 2024-04-01 2025-03-31 07972696 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07972696 bus:RegisteredOffice 2024-04-01 2025-03-31 07972696 bus:Director1 2024-04-01 2025-03-31 07972696 bus:Director1 1 2024-04-01 2025-03-31 07972696 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07972696 bus:Agent1 2024-04-01 2025-03-31 07972696 core:Goodwill 2024-04-01 2025-03-31 07972696 core:FurnitureFittings 2024-04-01 2025-03-31 07972696 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 07972696 core:LandBuildings 2024-04-01 2025-03-31 07972696 core:MotorVehicles 2024-04-01 2025-03-31 07972696 core:OtherProvisionsContingentLiabilities 2024-04-01 2025-03-31 07972696 countries:EnglandWales 2024-04-01 2025-03-31 07972696 2024-03-31 07972696 bus:Director1 1 2024-03-31 07972696 core:Goodwill 2024-03-31 07972696 core:CostValuation 2024-03-31 07972696 core:FurnitureFittingsToolsEquipment 2024-03-31 07972696 core:LandBuildings 2024-03-31 07972696 core:MotorVehicles 2024-03-31 07972696 2023-04-01 2024-03-31 07972696 2024-03-31 07972696 core:AcceleratedTaxDepreciationDeferredTax 2024-03-31 07972696 core:FinanceLeases core:CurrentFinancialInstruments 2024-03-31 07972696 core:CurrentFinancialInstruments 2024-03-31 07972696 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 07972696 core:Non-currentFinancialInstruments 2024-03-31 07972696 core:Goodwill 2024-03-31 07972696 core:MoreThanFiveYears 1 2024-03-31 07972696 core:FurnitureFittingsToolsEquipment 2024-03-31 07972696 core:LandBuildings 2024-03-31 07972696 core:MotorVehicles 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 07972696

Prepared for the registrar

RP Healthcare Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2025

 

RP Healthcare Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 11

 

RP Healthcare Ltd

Company Information

Director

R A Patel

Registered office

6 Elystan Street
Chelsea
London
SW3 3NS

Accountants

Hazlewoods LLP Staverton Court
Staverton
Cheltenham
GL51 0UX

 

RP Healthcare Ltd

(Registration number: 07972696)
Balance Sheet as at 31 March 2025

Note

2025
 £

(As restated)
2024
 £

Fixed assets

 

Intangible assets

4

708,410

752,504

Tangible assets

5

1,000,530

789,614

Investments

6

984,190

984,190

 

2,693,130

2,526,308

Current assets

 

Stocks

72,948

72,948

Debtors

7

2,086,189

1,569,885

Cash at bank and in hand

 

1,476,212

1,706,375

 

3,635,349

3,349,208

Creditors: Amounts falling due within one year

8

(2,393,144)

(1,906,052)

Net current assets

 

1,242,205

1,443,156

Total assets less current liabilities

 

3,935,335

3,969,464

Creditors: Amounts falling due after more than one year

8

(950,476)

(1,034,069)

Provisions

9

(13,010)

-

Deferred tax liabilities

11

(3,001)

(6,223)

Net assets

 

2,968,848

2,929,172

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

2,968,748

2,929,072

Total equity

 

2,968,848

2,929,172

 

RP Healthcare Ltd

(Registration number: 07972696)
Balance Sheet as at 31 March 2025

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 22 December 2025
 


R A Patel
Director

 

RP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
6 Elystan Street
Chelsea
London
SW3 3NS

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

 

RP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Land and buildings leasehold

15% Reducing balance basis

Fixtures, fittings and equipment

15% Reducing balance basis

Motor vehicles

20% Straight line basis

Goodwill

Goodwill is amortised over its useful life, estimated by the directors to be 20 years.

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

 

RP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Provisions

Provisions are recognised when the company has an obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

 

RP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the Balance Sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the Profit and Loss Account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.


Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.


Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

RP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was as follows:

 

RP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

5

Tangible assets

Leasehold
Land and buildings
£

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost

At 1 April 2024

733,983

122,803

118,219

975,005

Additions

256,532

4,968

-

261,500

Disposals

-

-

(62,000)

(62,000)

At 31 March 2025

990,515

127,771

56,219

1,174,505

Depreciation

At 1 April 2024

59,125

37,195

89,071

185,391

Charge for the year

16,204

12,566

15,614

44,384

Eliminated on disposal

-

-

(55,800)

(55,800)

At 31 March 2025

75,329

49,761

48,885

173,975

Carrying amount

At 31 March 2025

915,186

78,010

7,334

1,000,530

At 31 March 2024

674,858

85,608

29,148

789,614

The accounts for the year ended 2024 incorrectly included the disposal of leasehold land and buildings with a net book value of £554,746. A prior year adjustment has been included in these financial statements to reverse this disposal.

 

6

Investments

2025
£

2024
£

Investments in subsidiaries

984,190

984,190

Subsidiaries

£

Cost

At 1 April 2024 & 31 March 2025

984,190

Carrying amount

At 31 March 2025

984,190

At 31 March 2024

984,190

 

7

Debtors

Note

2025
£

2024
£

Trade debtors

 

161,775

168,136

Receivables from related parties

12

1,836,966

1,248,500

Prepayments

 

25,585

23,445

Other debtors

 

61,863

129,804

 

2,086,189

1,569,885

 

RP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

8

Creditors

Note

2025
 £

2024
 £

Due within one year

 

Loans and borrowings

10

147,902

150,023

Trade creditors

 

279,161

283,353

Amounts due to related parties

12

1,791,818

1,452,292

Social security and other taxes

 

-

5,175

Outstanding defined contribution pension costs

 

616

561

Other creditors

 

167,397

8,723

Accrued expenses

 

6,250

5,925

 

2,393,144

1,906,052

Due after one year

 

Loans and borrowings

10

950,476

1,034,069

The bank loans are secured over the assets of the company.

 

9

Provisions

NHS reimbursement
£

Total
£

Additional provisions

13,010

13,010

At 31 March 2025

13,010

13,010

The NHS reimbursement provision is to cover clawback of potential over-reimbursement received in the current financial year, which will be clawed back over the next 12 months via adjustment through Category M medicines.

 

10

Loans and borrowings

Current loans and borrowings

2025
£

2024
£

Bank borrowings

147,902

144,773

HP and finance lease liabilities

-

5,250

147,902

150,023

Non-current loans and borrowings

2025
£

2024
£

Bank borrowings

950,476

1,034,069

Included in the loans and borrowings are the following amounts due after more than five years:

2025
£

2024
£

After more than five years by instalments

474,068

511,342

-

-

The bank loans are secured over the assets of the company.

 

RP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

11

Deferred tax

Deferred tax assets and liabilities

2025

Liability
£

Difference between accumulated amortisation and depreciation and capital allowances

3,001

3,001

2024

Liability
£

Difference between accumulated amortisation and depreciation and capital allowances

6,223

6,223

 

12

Related party transactions

Transactions with the director

R A Patel
(Director)
As at the balance sheet date, the company owed the director £114,674 (2024 - the director owed the company £18,752). There are no fixed repayment terms.


 

2025

At 1 April 2024
£

Repayments by director
£

At 31 March 2025
£

R A Patel

Amounts owed to / (from) director

(18,752)

133,426

114,674



Transactions with other related parties

During the year, several related parties were identified. This has resulted in RP Healthcare Ltd being owed and owing money to its related parties. The balances at the year end were:

RP Healthcare Ltd was owed £1,836,966 (2024: £1,248,500) and;
RP Healthcare Ltd owes £1,791,818 (2024: £1,452,292).

There are no fixed repayment terms and no interest is charged.